Anticoagulation Intensity of Rivaroxaban for Stroke Patients at a Special Low Dosage in Japan

OBJECTIVES: In Japan, low-dose rivaroxaban [15 mg QD/10 mg QD for creatinine clearance of 30–49 mL/min] was approved for clinical use in NVAF patients partly because of its unique pharmacokinetics in Japanese subjects. The aim of the study was to determine the anticoagulation intensity of rivaroxaba...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:PLoS One
Main Authors: Okata, Takuya, Toyoda, Kazunori, Okamoto, Akira, Miyata, Toshiyuki, Nagatsuka, Kazuyuki, Minematsu, Kazuo
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2014
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4257912/
https://ncbi.nlm.nih.gov/pubmed/25479967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0113641
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker